A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
23 08 2019
Historique:
received: 30 04 2019
accepted: 15 07 2019
entrez: 25 8 2019
pubmed: 25 8 2019
medline: 27 5 2020
Statut: ppublish

Résumé

A dense population of embryo-derived Langerhans cells (eLCs) is maintained within the sealed epidermis without contribution from circulating cells. When this network is perturbed by transient exposure to ultraviolet light, short-term LCs are temporarily reconstituted from an initial wave of monocytes but thought to be superseded by more permanent repopulation with undefined LC precursors. However, the extent to which this process is relevant to immunopathological processes that damage LC population integrity is not known. Using a model of allogeneic hematopoietic stem cell transplantation, where alloreactive T cells directly target eLCs, we have asked whether and how the original LC network is ultimately restored. We find that donor monocytes, but not dendritic cells, are the precursors of long-term LCs in this context. Destruction of eLCs leads to recruitment of a wave of monocytes that engraft in the epidermis and undergo a sequential pathway of differentiation via transcriptionally distinct EpCAM

Identifiants

pubmed: 31444235
pii: 4/38/eaax8704
doi: 10.1126/sciimmunol.aax8704
pmc: PMC6894529
mid: NIHMS1056069
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI093870
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L001608/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1450227
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100156
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Blood. 2014 Oct 9;124(15):2411-20
pubmed: 25114264
Elife. 2017 Mar 10;6:
pubmed: 28282024
Front Immunol. 2018 Aug 15;9:1712
pubmed: 30158922
Eur J Immunol. 2003 Feb;33(2):314-25
pubmed: 12548562
Nat Commun. 2016 Jan 27;7:10321
pubmed: 26813785
J Immunol. 2002 May 1;168(9):4361-71
pubmed: 11970978
Cell. 2014 Dec 4;159(6):1327-40
pubmed: 25480297
Immunity. 2016 Apr 19;44(4):755-68
pubmed: 26992565
Blood. 2015 Jan 15;125(3):470-3
pubmed: 25352125
Blood. 2002 Sep 1;100(5):1734-41
pubmed: 12176895
J Exp Med. 2009 Dec 21;206(13):3089-100
pubmed: 19995948
Nat Med. 2004 May;10(5):510-7
pubmed: 15098028
Nat Immunol. 2012 Jun 24;13(8):744-52
pubmed: 22729248
Blood. 2000 Sep 1;96(5):1633-7
pubmed: 10961857
Immunity. 2004 Aug;21(2):279-88
pubmed: 15308107
Immunity. 2015 Aug 18;43(2):369-81
pubmed: 26231115
Blood. 2006 Feb 15;107(4):1383-90
pubmed: 16263793
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
J Exp Med. 2017 Aug 7;214(8):2387-2404
pubmed: 28694385
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Nat Methods. 2016 Jul;13(7):577-80
pubmed: 27240256
Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5736-E5745
pubmed: 29871951
Science. 2016 Sep 9;353(6304):
pubmed: 27492475
Immunity. 2012 Nov 16;37(5):905-16
pubmed: 23159228
Nat Rev Immunol. 2017 Jul;17(7):451-460
pubmed: 28461703
Eur J Cancer. 2016 Feb;54:139-148
pubmed: 26765102
Blood. 2014 Jan 9;123(2):217-27
pubmed: 24092934
Immunity. 2012 Dec 14;37(6):1050-1060
pubmed: 23177320
Front Immunol. 2018 Jan 05;8:1941
pubmed: 29379502
J Exp Med. 2009 Jan 16;206(1):169-81
pubmed: 19139172
Blood. 2012 Apr 19;119(16):3844-53
pubmed: 22101894
Cell Rep. 2016 Jun 14;15(11):2462-74
pubmed: 27264183
J Clin Invest. 2010 Nov;120(11):3855-68
pubmed: 20978352
Trends Immunol. 2010 Dec;31(12):438-45
pubmed: 21030305
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
J Exp Med. 2013 Aug 26;210(9):1657-64
pubmed: 23940255
Eur J Immunol. 2016 Mar;46(3):552-9
pubmed: 26634935
JCI Insight. 2018 Mar 8;3(5):
pubmed: 29515032
Nat Commun. 2016 Jun 13;7:ncomms11852
pubmed: 27292029
Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):E6917-26
pubmed: 26607449
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Cell. 2013 Aug 15;154(4):843-58
pubmed: 23953115
Cell. 2014 Dec 4;159(6):1312-26
pubmed: 25480296
J Exp Med. 2007 Dec 24;204(13):3119-31
pubmed: 18086861
Nat Immunol. 2017 Dec;18(12):1310-1320
pubmed: 29035391
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3084-7
pubmed: 1826563
Neuron. 2018 Jun 27;98(6):1170-1183.e8
pubmed: 29861285
J Clin Invest. 1997 Nov 15;100(10):2552-61
pubmed: 9366570
Nat Immunol. 2012 Jun 24;13(8):753-60
pubmed: 22729249
J Invest Dermatol. 2006 Nov;126(11):2452-7
pubmed: 16794586
Nat Immunol. 2006 Mar;7(3):265-73
pubmed: 16444257
J Exp Med. 2018 Jun 4;215(6):1627-1647
pubmed: 29643186
Nat Immunol. 2002 Dec;3(12):1135-41
pubmed: 12415265
J Exp Med. 2017 Oct 2;214(10):2933-2946
pubmed: 28814567
Nat Immunol. 2017 Sep 19;18(10):1068-1075
pubmed: 28926543
Cytokine. 2013 Jul;63(1):10-17
pubmed: 23684409
Immunity. 2018 Oct 16;49(4):595-613
pubmed: 30332628
Immunity. 2016 Sep 20;45(3):669-684
pubmed: 27637149
Mucosal Immunol. 2017 Nov;10(6):1387-1399
pubmed: 28145440
Cell. 1993 Feb 12;72(3):337-48
pubmed: 8381716
J Cell Biol. 2005 May 23;169(4):569-76
pubmed: 15897263
Immunity. 2005 May;22(5):643-54
pubmed: 15894281
J Immunol. 1999 Aug 1;163(3):1409-19
pubmed: 10415041
J Exp Med. 2018 Feb 5;215(2):481-500
pubmed: 29343501
Immunity. 2013 Nov 14;39(5):925-38
pubmed: 24184057
Immunity. 2015 Apr 21;42(4):665-78
pubmed: 25902481
J Exp Med. 2013 Dec 16;210(13):2967-80
pubmed: 24249112
Nat Immunol. 2002 Sep;3(9):844-51
pubmed: 12172545

Auteurs

Ivana R Ferrer (IR)

Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK and Cancer Institute Department of Haematology, Division of Cancer Studies, University College London, London WC1E 6DD, UK.

Heather C West (HC)

Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK and Cancer Institute Department of Haematology, Division of Cancer Studies, University College London, London WC1E 6DD, UK.

Stephen Henderson (S)

Bill Lyons Informatics Centre, Cancer Institute, University College London, London WC1E 6DD, UK.

Dmitry S Ushakov (DS)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, New Hunt's House, Newcomen Street, London SE1 1UL, UK.

Pedro Santos E Sousa (P)

Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK and Cancer Institute Department of Haematology, Division of Cancer Studies, University College London, London WC1E 6DD, UK.

Jessica Strid (J)

Division of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London W12 0NN, UK.

Ronjon Chakraverty (R)

Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK and Cancer Institute Department of Haematology, Division of Cancer Studies, University College London, London WC1E 6DD, UK.

Andrew J Yates (AJ)

Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA.

Clare L Bennett (CL)

Institute for Immunity and Transplantation, Division of Infection and Immunity, University College London, London NW3 2PF, UK and Cancer Institute Department of Haematology, Division of Cancer Studies, University College London, London WC1E 6DD, UK. c.bennett@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH